You are here

  • Home
  • Archive
  • Volume 16, Issue 1
  • In people with subclinical hypothyroidism, TSH level >10 mIU/l may predict increased risk of coronary heart disease and related mortality

Article Text

Article menu
Download PDFPDF
Aetiology
Systematic review
In people with subclinical hypothyroidism, TSH level >10 mIU/l may predict increased risk of coronary heart disease and related mortality
  1. Elizabeth N Pearce
  1. Boston University School of Medicine, Boston, Massachusetts, USA
  1. Correspondence to Elizabeth N Pearce
    88 East Newton Street, Evans 201, Boston, MA 02118, USA; Elizabeth.pearce{at}bmc.org

https://doi.org/10.1136/ebm1166

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on:

    1. Rodondi N,
    2. den Elzen WP,
    3. Bauer DC,
    4. et al
    .; Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010;304:1365–74.
    OpenUrlCrossRefPubMedWeb of Science

    Context

    Subclinical hypothyroidism, defined as an elevated thyroid-stimulating hormone (TSH) level with normal peripheral free thyroid hormone values, is highly prevalent, occurring in 4–10% of adults.1 Observational studies have identified associations between subclinical hypothyroidism and hyperlipidaemia and other atherosclerosis risk factors. However, it has been unclear whether subclinical hypothyroidism is associated with an increased risk for cardiovascular events and mortality. Results of several longitudinal studies and three previous study-level meta-analyses2,–,4 have been inconsistent. Individual-level meta-analyses had not previously been performed.

    Methods

    Rodondi and colleagues used a systematic literature search in all languages to identify potential studies for inclusion in a meta-analysis. MEDLINE and EMBASE databases and searches of key article bibliographies were used to identify articles describing associations between subclinical thyroid …

    View Full Text

    Footnotes

    • Competing interests EP has received consulting fees from Abbott Laboratories, the manufacturer of Synthroid.